AAAAAA

   
Results: 1-12 |
Results: 12
NITRIC-OXIDE AVAILABILITY IN DIABETES-MELLITUS
Authors: HONING MLH MORRISON PJ BANGA JD STROES ESG RABELINK TJ
Citation: Mlh. Honing et al., NITRIC-OXIDE AVAILABILITY IN DIABETES-MELLITUS, Diabetes/metabolism reviews, 14(3), 1998, pp. 241-249
DIVERGENT EFFECTS OF ACE-INHIBITION AND CALCIUM-CHANNEL BLOCKADE ON NO-ACTIVITY IN SYSTEMIC AND RENAL CIRCULATION IN ESSENTIAL-HYPERTENSION
Authors: DIJKHORSTOEI LT BEUTLER JJ STROES ESG KOOMANS HA RABELINK TJ
Citation: Lt. Dijkhorstoei et al., DIVERGENT EFFECTS OF ACE-INHIBITION AND CALCIUM-CHANNEL BLOCKADE ON NO-ACTIVITY IN SYSTEMIC AND RENAL CIRCULATION IN ESSENTIAL-HYPERTENSION, Cardiovascular Research, 40(2), 1998, pp. 402-409
ENDOTHELIN BLOCKERS AND RENAL PROTECTION - A NEW STRATEGY TO PREVENT END-ORGAN DAMAGE IN CARDIOVASCULAR-DISEASE
Authors: RABELINK TJ STROES ESG BOUTER KP MORRISON P
Citation: Tj. Rabelink et al., ENDOTHELIN BLOCKERS AND RENAL PROTECTION - A NEW STRATEGY TO PREVENT END-ORGAN DAMAGE IN CARDIOVASCULAR-DISEASE, Cardiovascular Research, 39(3), 1998, pp. 543-549
HYPOALBUMINEMIA INCREASES LYSOPHOSPHATIDYLCHOLINE IN LOW-DENSITY-LIPOPROTEIN (LDL)
Authors: JOLES JA STROES ESG WILLEKESKOOLSCHIJN N RABELINK TJ KOOMANS HA
Citation: Ja. Joles et al., HYPOALBUMINEMIA INCREASES LYSOPHOSPHATIDYLCHOLINE IN LOW-DENSITY-LIPOPROTEIN (LDL), Journal of the American Society of Nephrology, 8, 1997, pp. 340-340
CYCLOSPORINE-A INCREASES NITRIC-OXIDE ACTIVITY IN-VIVO
Authors: STROES ESG LUSCHER TF DEGROOT FG KOOMANS HA RABELINK TJ
Citation: Esg. Stroes et al., CYCLOSPORINE-A INCREASES NITRIC-OXIDE ACTIVITY IN-VIVO, Hypertension, 29(2), 1997, pp. 570-575
MECHANISMS OF CARDIOVASCULAR INJURY IN RENAL-DISEASE
Authors: RABELINK TJ STROES ESG KOOMANS HA
Citation: Tj. Rabelink et al., MECHANISMS OF CARDIOVASCULAR INJURY IN RENAL-DISEASE, Blood purification, 14(1), 1996, pp. 67-74
ENDOTHELIN IN RENAL PATHOPHYSIOLOGY - FROM EXPERIMENTAL TO THERAPEUTIC APPLICATION
Authors: RABELINK TJ KAASJAGER KAH STROES ESG KOOMANS HA
Citation: Tj. Rabelink et al., ENDOTHELIN IN RENAL PATHOPHYSIOLOGY - FROM EXPERIMENTAL TO THERAPEUTIC APPLICATION, Kidney international, 50(6), 1996, pp. 1827-1833
CYCLOSPORINE-A (CSA) IS ASSOCIATED WITH AN INCREASED NITRIC-OXIDE ACTIVITY IN HUMANS
Authors: STROES ESG OEMAR B LUSCHER TF KOOMANS HA RABELINK TJ
Citation: Esg. Stroes et al., CYCLOSPORINE-A (CSA) IS ASSOCIATED WITH AN INCREASED NITRIC-OXIDE ACTIVITY IN HUMANS, Kidney international, 50(5), 1996, pp. 1817-1817
VASCULAR FUNCTION IN THE FOREARM OF HYPERCHOLESTEROLEMIC PATIENTS OFFAND ON LIPID-LOWERING MEDICATION
Authors: STROES ESG KOOMANS HA DEBRUIN TWA RABELINK TJ
Citation: Esg. Stroes et al., VASCULAR FUNCTION IN THE FOREARM OF HYPERCHOLESTEROLEMIC PATIENTS OFFAND ON LIPID-LOWERING MEDICATION, Lancet, 346(8973), 1995, pp. 467-471
IMPAIRED ENDOTHELIAL FUNCTION IN PATIENTS WITH NEPHROTIC RANGE PROTEINURIA (NS)
Authors: STROES ESG JOLES JA CHANG PC KOOMANS HA RABELINK TJ
Citation: Esg. Stroes et al., IMPAIRED ENDOTHELIAL FUNCTION IN PATIENTS WITH NEPHROTIC RANGE PROTEINURIA (NS), Kidney international, 48(4), 1995, pp. 1363-1363
IMPAIRED ENDOTHELIAL FUNCTION IN PATIENTS WITH NEPHROTIC RANGE PROTEINURIA
Authors: STROES ESG JOLES JA CHANG PC KOOMANS HA RABELINK TJ
Citation: Esg. Stroes et al., IMPAIRED ENDOTHELIAL FUNCTION IN PATIENTS WITH NEPHROTIC RANGE PROTEINURIA, Kidney international, 48(2), 1995, pp. 544-550
ENDOTHELIAL DYSFUNCTION IN NEPHROTIC SYNDROME (NS)
Authors: STROES ESG KOOMANS HA CHANG PC RABELINK AJ
Citation: Esg. Stroes et al., ENDOTHELIAL DYSFUNCTION IN NEPHROTIC SYNDROME (NS), Journal of the American Society of Nephrology, 5(3), 1994, pp. 592-592
Risultati: 1-12 |